This invention is directed to substituted aryl compounds, which are linked to a substituted indole moiety by various linkers, and the kynurenine/kynuramine-like metabolites of these agents, their preparation and pharmaceutical compositions containing these compounds. This invention further is directed to the pharmaceutical use of the compounds for inhibiting GSK3β kinase and/or modulating N-methyl-D-aspartate (NMDA) channel activities for the treatment of neurodegenerative and other disorders.
本发明涉及通过各种连接剂与取代的
吲哚分子相连的取代芳基化合物,以及这些制剂的犬尿
氨酸/犬尿
氨酸样代谢物、其制备方法和含有这些化合物的药物组合物。本发明进一步涉及这些化合物的药物用途,用于抑制 GSK3β 激酶和/或调节
N-甲基-D-天冬氨酸(N
MDA)通道活性,以治疗神经退行性疾病和其他疾病。